Source: MedRXiv. Unidade: FMRP
Subjects: ANTIRRETROVIRAIS, COVID-19, ENSAIO CLÍNICO, AGENTE TÓXICO
ABNT
ARRUDA, E. A. G. et al. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, p. 1-27, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.09.28.21264242. Acesso em: 02 maio 2026.APA
Arruda, E. A. G., Pires-Neto, R. J., Medeiros, M. S., Quirino-Filho, J., Clementino, M., Gondim, R. N. D. G., et al. (2021). Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections. MedRXiv, 1-27. doi:10.1101/2021.09.28.21264242NLM
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2026 maio 02 ] Available from: https://doi.org/10.1101/2021.09.28.21264242Vancouver
Arruda EAG, Pires-Neto RJ, Medeiros MS, Quirino-Filho J, Clementino M, Gondim RNDG, Magalhães LMVC, Cavalcante KF, Viana VAF, Mello LP, Martins RB, Santos AA, Magalhães PJC, Havt A, Lopes NP, Arruda Neto E de, Lima AAM. Clinical trial of efficacy and toxicity of disoproxil tenofovir fumarate and emtricitabine for mild to moderate SARS-CoV-2 infections [Internet]. MedRXiv. 2021 ; 1-27.[citado 2026 maio 02 ] Available from: https://doi.org/10.1101/2021.09.28.21264242
